Central Pacific Bank Trust Division Boosts Stake in Chemed Co. (NYSE:CHE)

Central Pacific Bank Trust Division grew its stake in Chemed Co. (NYSE:CHE) by 11.4% during the fourth quarter, HoldingsChannel reports. The fund owned 880 shares of the company’s stock after acquiring an additional 90 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Chemed were worth $466,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CHE. EP Wealth Advisors LLC raised its holdings in Chemed by 1.9% in the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after purchasing an additional 25 shares in the last quarter. Ballentine Partners LLC raised its stake in shares of Chemed by 4.1% during the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock worth $394,000 after acquiring an additional 26 shares in the last quarter. Creative Planning lifted its position in Chemed by 2.8% during the second quarter. Creative Planning now owns 1,228 shares of the company’s stock valued at $667,000 after acquiring an additional 34 shares during the last quarter. First Heartland Consultants Inc. grew its holdings in Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after purchasing an additional 34 shares during the last quarter. Finally, First Trust Direct Indexing L.P. increased its position in shares of Chemed by 4.5% during the third quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock worth $533,000 after purchasing an additional 38 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Insider Activity

In other news, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares of the company’s stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.

Chemed Trading Up 1.3 %

NYSE:CHE opened at $535.00 on Friday. The firm has a fifty day simple moving average of $549.03 and a 200-day simple moving average of $562.67. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $654.62. The company has a market capitalization of $8.05 billion, a P/E ratio of 27.03, a PEG ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same period in the prior year, the firm posted $5.32 EPS. The business’s revenue was up 7.4% compared to the same quarter last year. Equities analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.37%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s payout ratio is 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.